Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Dec 15, 2017
    Medtronic Settles With Five States for $12 Million Over Infuse Marketing
  • Dec 12, 2017
    Bad Ad Studies Move Forward
  • Dec 11, 2017
    FDA Issues Final Guidance on Product Names Used in Ads and Promotional Labeling
  • Dec 11, 2017
    CSPI Asks FDA, FTC To Take Action on Opioid Withdrawal Aid Supplements
  • Dec 11, 2017
    Opioid Lawsuits Combined in Ohio District Court
  • Dec 7, 2017
    Appeals Court Panel Rules Against Whistleblower
  • Dec 7, 2017
    Montana Sues Purdue Over Deceptive Opioid Marketing
  • Dec 4, 2017
    OIG Rescinds Advisory Opinion on Patient Assistance Program
  • Dec 1, 2017
    Supplement Company, Owner Settle with FTC, Maine
  • Dec 1, 2017
    National Academies Report Calls for Repeal of DTC Advertising Tax Deduction
  • More

Good Clinical Practice

  • Apr 23, 2018
    CBER Issues Tech Specs for Vaccine Submissions
  • Apr 19, 2018
    Neb. Governor Approves ‘Right-to-Try’ Bill
  • Apr 19, 2018
    Feds Propose Delaying Revised Common Rule Until January 2019
  • Apr 19, 2018
    Grassley Probes Two Questionable Trials
  • Apr 18, 2018
    ClinicalTrials.gov Adds Three FAQs
  • Apr 16, 2018
    FDA Offers Streamlined Process for Determining If an IVD in an Oncology Trial is Significant Risk
  • Apr 3, 2018
    FDA Issues PRO Guidance for COPD Trials
  • Mar 31, 2018
    CROs Start Industry Standards Group
  • Mar 28, 2018
    Comparison of U.S.-EU Registries Finds Different Completion Statuses for Trials
  • Mar 28, 2018
    Mayo Clinic Uses Watson AI for Trial Matching
  • More

U.S. Food Labeling

  • Jan 24,2013
    FSIS Labeling Proposal for Artificially Tenderized Meat Products Languishing in Extended OMB Review
  • Jan 22,2013
    FDA Seeks Feedback on Notification Requirements for Supplement Claims
  • Jan 21,2013
    FDA Hails 20-Year Anniversary of Nutrition Facts Box Rule
  • Jan 17,2013
    FDA Clears ‘No Drain Canned Tuna’ Standards Change for Market Test
  • Jan 3,2013
    FDA Proposal Looks To Eliminate Obsolete Naming Standards for Artificially Sweetened Fruit Spreads
  • Jan 3,2013
    CFSAN Sets 2016 Compliance Deadline for All Labeling Regulations Issued Over Next Two Years
  • Jan 2,2013
    FDA District Offices Fire Off Three Warning Letters To Supplement Makers, One to Food Manufacturer
  • Dec 14,2012
    FDA District Offices Clamp Down on Health Claims, Fire Off Warning Letters for Foods and Supplements
  • Dec 13,2012
    Agricultural Marketing Service Rule Imposes New Testing Requirements for Produce Labeled ‘Organic’
  • Dec 10,2012
    Proposed Risk Assessment for Major Allergens Could Make Label Exemptions Harder to Secure
  • More

FDA Regulation & Enforcement

  • Jan 7, 2021
    FDA Warns Retailer About Undeclared Allergens
  • Jan 6, 2021
    FDA Debars Three Former Insys Executives
  • Dec 29, 2020
    Another Supplement Company and its Owner Plead Guilty to Charge of Marketing Unapproved SARMs
  • Dec 29, 2020
    Senate Report Calls for Adding Payments to Tax-exempt Groups to Open Payments Database
  • Dec 24, 2020
    Device Company CEO Charged with Securities Fraud for Falsely Claiming Development of COVID-19 Test
  • Dec 23, 2020
    Court: Product Liability Claims Involving Contaminated Valsartan Not Preempted under FD&C Act, DSCSA
  • Dec 23, 2020
    FDA Finalizes Labeling Guidance on Alternate Name for Potassium Chloride
  • Dec 21, 2020
    Drug Company and Specialty Pharmacy Settle False Claims Act Case Over Payments to Foundations
  • Dec 16, 2020
    N.C. Company, Owner Plead Guilty to Marketing Unapproved Steroid-like Drugs as Sports Supplements
  • Dec 16, 2020
    Catheter Maker Issues Urgent Recall of Device Following Reports of 14 Deaths, Hundreds of Injuries
  • More

Medical Devices

  • Oct 1, 2015
    Proposed Rule Would Drop ‘Knowledge Prong’ from Regulatory Definition of ‘Intended Use’ for Devices
  • Sep 25, 2015
    Ubl Will Leave AdvaMed To Become President and CEO at PhRMA
  • Sep 24, 2015
    Analogic Proposes $1.6 Million Settlement To Resolve SEC Investigation into Subsidiary
  • Sep 24, 2015
    FDA Continues Push for Patient Preference Input on Devices with New Advisory Committee
  • Sep 16, 2015
    FDA Public Workshops Scheduled for November Will Explore Aspects of Regulating NGS Diagnostic Tests
  • Sep 15, 2015
    Obama Nominates Dr. Robert M. Califf as Next FDA Commissioner
  • Sep 1, 2015
    Pilot Program Will Test Harmonized Device Submission Formats Developed by IMDRF on PMAs, 510(k)s
  • Aug 31, 2015
    FDA Calls for Device Makers To Volunteer for Summary Quarterly Malfunction Reporting Pilot Program
  • Aug 31, 2015
    FCC Clarifies Rules for RF-Based Devices
  • Aug 27, 2015
    FDA Increases Fees Charged for Medical Device Export Certificates
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.